Sun’s products are part of the long-listed and established prescription brands and includes Parlodel, Lamsil, Nitroderm and Lopressor.

A new anti-diabetes drug from the 'gliptin' family soon to be launched in India promises to lower treatment cost for patients by 55-60%.